A new method for muting malaria turns one of the parasite’s proteins into a self-destruction device

It’s been a busy time for infectious disease vaccine news in Europe.

The DNDi is doing incredible work across the world. In this digital feature, we explore a portion of these open science efforts.

Cell and gene therapy manufacturers need to make better plasmid design decisions with commercialization in mind.

Academia-industry collaboration doesn’t have to be difficult; we just need to appreciate one another’s differences.

Single-use technology continues to evolve; single-use bags are now a robust alternative to using bottles in freeze and thaw.

This is the story of how DNDi put forward a new model for collaborative, open science.

What links the DNDi and one of Google’s most futuristic AI assets? We get the story from DeepMind’s protein premier.

What are the biggest lessons that the pharma industry has learned from the COVID-19 pandemic?

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.